πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 218 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9732110

Nucleoside and nucleotide derivatives

Enanta Pharmaceuticals, Inc. Β· Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9718851

Deuterated nucleoside/tide derivatives

Enanta Pharmaceuticals, Inc. Β· Granted Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9676802

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9675632

Nucleoside and nucleotide derivatives

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9669095

Cyclosporin analogues for preventing or treating hepatitis C infection

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9616099

Cyclosporin analogues for preventing or treating hepatitis C infection

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9603895

Cyclosporin analogues for preventing or treating hepatitis C infection

Enanta Pharmaceuticals, Inc. Β· Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9526769

Macrocylic oximyl hepatitis C protease inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9309279

Macrocyclic hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9220748

Macrocyclic proline derived HCV serine protease inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9221878

Cyclosporin analogues for preventing or treating hepatitis C infection

Enanta Pharmaceuticals, Inc. Β· Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9193740

Bismacrocyclic compounds as hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9156818

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9156886

Cyclosporin analogues for preventing or treating hepatitis C infection

Enanta Pharmaceuticals, Inc. Β· Granted Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9127021

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9085599

2β€²allene-substituted nucleoside derivatives

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9060971

Combination pharmaceutical agents as inhibitors of HCV replication

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9000020

Linked dibenzimidazole antivirals

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8962551

Quinoxalinyl derivatives

Enanta Pharmaceuticals, Inc. Β· Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8951964

Phenanthridine macrocyclic hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8951998

Quinoxaline-containing compounds as hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8940688

Fluorinated tripeptide HCV serine protease inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8936781

Macrocyclic compounds as hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8933110

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted